Malignant News and Research

RSS

Spatial orgnization of the genome can be altered using small molecules

Researchers have discovered that the spatial organization of the genome can be altered using small molecule compounds which are considered as promising anti-cancer drugs.

16 Apr 2019

Leica Microsystems receives FDA De Novo clearance for blue light fluorescence module

Leica Microsystems has received DeNovo clearance from the FDA to market its FL400 surgical microscope filter in the United States for characterization of tumor tissue in neurosurgery.

From Leica Microsystems GmbH 15 Apr 2019

Research group develops extremely sensitive pancreatic cancer diagnostic method

Thus, the prospects for early pancreatic cancer detection are of enormous importance. Innovation Fund Denmark has just granted 13.1 million kroner for new and promising pancreatic cancer diagnostic technologies.

12 Apr 2019

Experts in coloproctology will unite to promote global collaboration at 14th Annual ESCP conference

The 14th Annual ESCP conference, which unites global experts in coloproctology, will hear from several prolific key speakers over the course of three days, sharing research, innovation and best practice in Vienna this September.

12 Apr 2019

Study describes vulnerability shared by large subset of cancer cell lines

Cancer cells adapt to potentially fatal mutations and other molecular malfunctions by adjusting one or more other genes' activity, in the process becoming dependent on those genes for their survival and growth.

12 Apr 2019

Jewish General Hospital initiates new clinical trial to avoid surgery in breast cancer patients

In a radical departure from established treatment protocols, Dr. Mark Basik, a surgical oncologist at Segal Cancer Centre at the Jewish General Hospital and senior investigator at the Lady Davis Institute, is leading an international effort that will lead to a clinical trial to forego surgery in breast cancer patients who show no signs of residual cancer following a course of pre-operative chemotherapy.

9 Apr 2019

Biologists analyze available methods of targeted drug delivery to malignant tumors

A team of biologists from Sechenov First Moscow State Medical University and Lobachevsky University analyzed available methods of targeted drug delivery to malignant tumors.

9 Apr 2019

Blood-based test for colon cancer shows promise, study finds

If caught early, nearly all cases of colon cancer are curable. Though this should make screening tests straightforward, colon cancer screening suffers from a paradoxical combination of low compliance rates and overdiagnosis.

9 Apr 2019

Cancer vaccine injected into tumour could kill all cancer cells

Researchers have developed an experimental cancer vaccine that when injected into a single tumour can help trigger the immune system to kill the cancer cells circulating within the body. The results of the study titled, “Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination,” were published in the latest issue of the journal Nature Medicine, this week, Monday.

9 Apr 2019

Children born via IVF more likely to develop cancer later in life

Scientists investigating have discovered a notable link between childhood cancer development and IVF.

3 Apr 2019

Protein discovery opens door for new options in diagnosis and therapy of cancer

Oncologists at the University and University Hospital in Tübingen have discovered a new protein variant that plays an important role in the development and therapy response of cancer.

3 Apr 2019

Research demonstrates clinical utility of ddPCR-powered liquid biopsy at 2019 AACR Annual Meeting

New research demonstrating the clinical utility of Bio-Rad's Droplet Digital PCR powered liquid biopsy will be presented this week during the 2019 American Association for Cancer Research Annual Meeting in Atlanta, March 29-April 3.

30 Mar 2019

Cancer prevention drug also reduces virulence of H. pylori bacterium

A medicine currently being tested as a chemoprevention agent for multiple types of cancer has more than one trick in its bag when it comes to preventing stomach cancer, Vanderbilt researchers have discovered.

29 Mar 2019

Tumor-associated macrophages block activity of chemotherapy drug in pancreatic cancer

A frontline chemotherapy drug given to patients with pancreatic cancer is made less effective because similar compounds released by tumor-associated immune cells block the drug's action, research led by the University of Michigan Rogel Cancer Center found.

27 Mar 2019

BU researchers identify biomarker and possible new therapy for melanoma

Researchers have identified a biomarker and a possible new therapy for melanoma.

26 Mar 2019

Preclinical data shows combination immunotherapy could suppress tumor growth in the liver

Even as overall cancer incidence and mortality decrease in the United States, the number of people diagnosed with liver cancer is on the rise.

14 Mar 2019

Novel biosensor can isolate and target leukemic stem cells

All stem cells can multiply, proliferate and differentiate. Because of these qualities, leukemic stem cells are the most malignant of all leukemic cells. Understanding how leukemic stem cells are regulated has become an important area of cancer research.

12 Mar 2019

Bacteria from seawater provide new leads to treat malignant melanoma

Malignant melanoma can be a particularly dangerous form of cancer, and more therapeutic options are needed. Now, researchers report in ACS Medicinal Chemistry Letters that a bacteria from seawater has inspired promising leads for an entirely new way to treat the disease.

7 Mar 2019

Artificial intelligence systems may detect breast cancer as accurately as radiologists

A new paper in the Journal of the National Cancer Institute suggests that artificial intelligence systems may be able to perform as accurately as radiologists in the evaluation of digital mammography in breast cancer screening.

6 Mar 2019

Research opens door to promising new treatment strategy for deadly brain tumor in children

A study published in Nature Communications found that an inhibitor of an enzyme called ACVR1 slows tumor growth and increases survival in an animal model of diffuse intrinsic pontine glioma - the most deadly brain tumor in children.

4 Mar 2019

Malignant News and Research

Spatial orgnization of the genome can be altered using small molecules

Leica Microsystems receives FDA De Novo clearance for blue light fluorescence module

Research group develops extremely sensitive pancreatic cancer diagnostic method

Experts in coloproctology will unite to promote global collaboration at 14th Annual ESCP conference

Study describes vulnerability shared by large subset of cancer cell lines

Jewish General Hospital initiates new clinical trial to avoid surgery in breast cancer patients

Biologists analyze available methods of targeted drug delivery to malignant tumors

Blood-based test for colon cancer shows promise, study finds

Cancer vaccine injected into tumour could kill all cancer cells

Children born via IVF more likely to develop cancer later in life

Protein discovery opens door for new options in diagnosis and therapy of cancer

Research demonstrates clinical utility of ddPCR-powered liquid biopsy at 2019 AACR Annual Meeting

Cancer prevention drug also reduces virulence of H. pylori bacterium

Tumor-associated macrophages block activity of chemotherapy drug in pancreatic cancer

BU researchers identify biomarker and possible new therapy for melanoma

Preclinical data shows combination immunotherapy could suppress tumor growth in the liver

Novel biosensor can isolate and target leukemic stem cells

Bacteria from seawater provide new leads to treat malignant melanoma

Artificial intelligence systems may detect breast cancer as accurately as radiologists

Research opens door to promising new treatment strategy for deadly brain tumor in children

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News